Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04618471 · ClinicalTrials.gov registry record · NA
Paresthesia-Free Fast-Acting Subperception (FAST) Study
A NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
- Active
- Registry status
- NA
- Development phase
- 177
- Enrollment target
- 13
- Study locations
NCT04618471: Active NA study of Chronic Pain, sponsored by Boston Scientific Corporation.
NCT04618471 is a NA study of Chronic Pain that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 177 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (77% lower). The trial reports 13 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04618471, a NA study of Chronic Pain, is active but no longer recruiting, sponsored by Boston Scientific Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
- 13
- Study locations
Study Summary
Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.
Primary Outcome
Proportion of subjects with 50% or greater reduction from Baseline Visit in average targeted pain intensity at 3 months post-activation
Conditions Studied
Interventions
- DEVICE Boston Scientific WaveWriter SCS System
Study Locations (13)
Florida
- Orlando Health Neuroscience Institute - Clermont
- The Orthopaedic Institute - Gainesville
California
- Vitamed Research - Palm Desert
Colorado
- Denver Back Pain Specialists - Greenwood Village
Illinois
- University of Chicago Hospital - Chicago
Indiana
- Goodman Campbell Brain and Spine - Carmel
Louisiana
- Willis-Knighton River Cities Clinical Research Center - Shreveport
New York
- Montefiore Medical Center - The Bronx
North Carolina
- The Center for Clinical Research - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2029-03 |
| Phase | NA |
What the registry record for NCT04618471 still lists
NCT04618471 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Boston Scientific WaveWriter SCS System is the first listed.
NCT04618471 lists 13 locations in 12 states (Florida, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT04618471 about?
NCT04618471 is a clinical study titled "Paresthesia-Free Fast-Acting Subperception (FAST) Study". Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.
What is the current status of trial NCT04618471?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2021-02-10. Estimated completion is 2029-03.
What conditions does trial NCT04618471 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT04618471?
The interventions under investigation include: Boston Scientific WaveWriter SCS System (DEVICE).
Who is sponsoring clinical trial NCT04618471?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04618471 being conducted?
This trial has 13 study locations across California, Colorado, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04618471's enrollment target sits among peer trials
177 94th of 301 higher than 207 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI